{"id":"W2612422239","doi":"10.1182/blood-2016-12-758383","title":"Safety and tolerability of pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":295,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; H. Lundbeck A/S; Università di Bologna; Argenx; PharmaMar; Celgene; Gilead Sciences; Servier; Amgen; Pfizer; Bristol-Myers Squibb","keywords":"Pembrolizumab; Medicine; Tolerability; Refractory (planetary science); Internal medicine; Lymphoma; Oncology; Adverse effect; Immunotherapy; Cancer; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009941217,0.0003320283,0.0008259852,0.0001860744,0.0002164505,0.0004072473,0.0001942728,0.0003859346,0.0008348349],"category_scores_gemma":[0.001292312,0.0001668444,0.0004579467,0.0002023491,0.0002535535,0.000345801,0.0001441246,0.001015873,0.0002969169],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003394341,"about_ca_system_score_gemma":0.0002911224,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003130698,"about_ca_topic_score_gemma":0.0006465584,"domain_scores_codex":[0.9996829,0.0001600874,0.00002832645,0.00003816815,0.00004934772,0.0000411113],"domain_scores_gemma":[0.9995247,0.0001436715,0.0001391761,0.0000361183,0.00003068661,0.0001255827],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2592494,0.01113851,0.132939,0.0008868431,0.001391872,0.002063322,0.000700105,0.004962166,0.1536088,0.0002208047,0.003574573,0.4292645],"study_design_scores_gemma":[0.05486513,0.3795837,0.5230052,0.0001419254,0.001363955,0.004276903,0.0002571313,0.007155443,0.02092979,0.0003473228,0.008001924,0.00007159555],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974287,0.0013365,0.0002287587,0.0001208655,0.00001506114,0.00007717319,0.0001538412,0.00003156579,0.000607492],"genre_scores_gemma":[0.9988794,0.0003354577,0.000177683,0.0001274579,0.00003821126,0.00006236649,0.0001999749,0.000005092644,0.0001743188],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0009941217,"threshold_uncertainty_score":0.005257428,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005873927897826031,"score_gpt":0.2133130162728942,"score_spread":0.2074390883750681,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}